International | Tissuepathology.com

Lumea Receives Global Recognition Award for Exceptional Achievement

Erica Goodpaster — Tue, 28 Jul 2026 12:50:34 +0000

From the Lumea blog: We are thrilled to announce that we received a global award for exception achievement from the international awards program The Global Recognition Awards™. We couldn’t be prouder of our team and the countless hours they’ve put into revolutionizing cancer diagnostics and digital pathology by raising the standard for tissue quality with our software […]

The post Lumea Receives Global Recognition Award for Exceptional Achievement first appeared on Tissuepathology.com.

Aiforia brings AI-assisted lung cancer analysis to NHS pathology workflows

Erica Goodpaster — Mon, 27 Jul 2026 12:13:32 +0000

Aiforia is helping University Hospital Southampton NHS Foundation Trust support faster, more consistent pathology workflows on Microsoft Azure through AI-assisted lung cancer analysis. For years, the promise of AI has been to empower people to work more efficiently, make better decisions, and focus attention where it matters most. In healthcare, that promise carries particular weight. […]

The post Aiforia brings AI-assisted lung cancer analysis to NHS pathology workflows first appeared on Tissuepathology.com.

Ibex Medical Analytics Achieves CE-IVDR Certification for Breast Panel IHCs, Elevating the Standard of Care in AI-Powered Breast Cancer Diagnostics

Erica Goodpaster — Fri, 24 Jul 2026 12:06:23 +0000

Ibex: The clinical validation and regulatory certification of Ibex’s breast IHC workflow is expected to further boost pathology lab performance and enhance patient care BOSTON & TEL AVIV, Israel–(BUSINESS WIRE)–Ibex Medical Analytics (Ibex), the global leader in AI-powered pathology solutions for clinical diagnostics and biopharma, today announced that it has received In Vitro Diagnostic Medical […]

The post Ibex Medical Analytics Achieves CE-IVDR Certification for Breast Panel IHCs, Elevating the Standard of Care in AI-Powered Breast Cancer Diagnostics first appeared on Tissuepathology.com.

Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform

Erica Goodpaster — Wed, 22 Jul 2026 12:13:49 +0000

OREM, UT, UNITED STATES, July 21, 2026 /EINPresswire.com/ — Techcyte, a worldwide leader in AI-powered digital pathology and diagnostics, today announced it has surpassed 11 million AI-assisted scans processed across active customer environments spanning human, veterinary, and environmental diagnostic platforms. The milestone marks a significant step in the company’s mission to make AI-driven diagnostics accessible to […]

The post Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform first appeared on Tissuepathology.com.

Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule

Erica Goodpaster — Tue, 21 Jul 2026 11:30:50 +0000

Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions. Optiscan Imaging (ASX: OIL) has begun Stage 2 of its first-in-human head and neck cancer imaging study at St John of God Murdoch Hospital in Perth ahead of schedule. The hospital’s Human Research Ethics […]

The post Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule first appeared on Tissuepathology.com.

Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology

Erica Goodpaster — Fri, 10 Jul 2026 12:29:58 +0000

July 9, 2026 – Lumito AB (publ) (“Lumito” or the “Company”) today announces that the Company has initiated a pilot project together with the Swedish biotech company Navinci Diagnostics AB (”Navinci”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis […]

The post Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology first appeared on Tissuepathology.com.